Gordian Biotechnology

The success of AI applied to drug discovery is being decided by a number of clinical trials. So far, the results are lackluster. Why? For AI to have a transformational effect in drug discovery, training data must come from living mammals. (🧵1/9)

@GordianBio has a sponsor ticket to @ARDD_Meeting that we want to give away! We are supporting the conference as a major forum for the translation of aging biology into treatments that impact humans. Accomplishing this goal at scale will take more than academic and biotech…

If you're at #ENDO2025 come check out @GordianBio posters: 🐒 SUN-697 on pooled in vivo therapeutic screening in primate models of metabolic syndrome (>2 years on Western diet, diabetic, MASH & more). 🫀MON-698 on new therapies and physiological predictive power of in vivo…

Just realized that this year @GordianBio passed 50M individually perturbed cells sequenced to measure the in vivo effects of therapeutic targets. We're on the way to turn results into drugs for diseases with no cures, but it's a cool milestone along the way.

Our CEO discussed the latest developments at Gordian with Danny Sullivan, including partnering efforts, cures for OA, and vision for the future.

This news should instill urgency and remind us to ask ‘why not sooner?’. @MartinBJensen shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen. gordian.bio/blog/cures-on-…

Moira Gunn from BioTech Nation (@biotechnation) hosted a very interesting and insightful interview talking about Reprogramming the Future with Martin Borch Jensen and Francisco LePort from Gordian Biotechnology (@GordianBio) biotechnation.com/episodes/repro…